Method of diagnosing pneumonia by detecting a volatile organic compound
AssigneeMeon Medical Solutions GmbH & Co KG
InventorsHorst Ruether, Anton Amann
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of diagnosing an existing or developing acute pneumonia induced by a microorganism by detecting one or more volatile organic compound(s) in a subject's sample and the use of one or more volatile organic compound(s) for the detection of Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pneumoniae or Haemophilus influenza and optionally opportunistic pathogen Candida albicans.
Claims21
A method of diagnosing an existing or developing acute pneumonia induced by a microorganism comprising:
- a) obtaining a respiratory air sample from a subject,
- b) detecting one or more volatile organic compound(s) in the respiratory air sample without culturing the respiratory air sample prior to the detecting, wherein the volatile organic compound is selected from the group consisting of 2-ethylacrolein, 2-methyl-2-butenal (Z), ethyl formate, ethyl isovalerate, isopentyl acetate, hydroxyacetone, 2-butanol, 2-methylbutyl 2-methylbutyrate, 2-methylbutyl isobutyrate, amyl isovalerate, ethyl 2-methylbutyrate, isoamyl butyrate, methyl 2-methylbutyrate, 1,10-undecadiene, 10-methyl-1-undecene, 1-decene, 1-nonene, 1-vinyl aziridine, mercaptoacetone, 3-phenylfuran, 3-(methylthio)propanal, o-hydroxybenzaldehyde, methyl propionate, vinyl butyrate, 2-acetyl-1,4,5,6-tetrahydropyridine, S-methyl thioacetate, 3-methyl-1-butanol, 3-(ethylthio)-propanal, 1-butanol, dimethyltrisulfide (DMTS), methyl methacrylate, and
- c) administering an effective amount of an antibiotic to the subject when the one or more volatile organic compound(s) in the sample are detected in the respiratory air sample.
A method of detecting one or more volatile organic compound(s) in a subject's respiratory air sample, wherein the volatile organic compound(s) is detected in the respiratory air sample without culturing the respiratory air sample prior to the detecting and wherein the volatile organic compound is selected from the group consisting of 2-ethylacrolein, 2-methyl-2-butenal (Z), ethyl formate, ethyl isovalerate, isopentyl acetate, hydroxyacetone, 2-butanol, 2-methylbutyl 2-methylbutyrate, 2-methylbutyl isobutyrate, amyl isovalerate, ethyl 2-methylbutyrate, isoamyl butyrate, methyl 2-methylbutyrate, 1,10-undecadiene, 10-methyl-1-undecene, 1-decene, 1-nonene, 1-vinyl aziridine, mercaptoacetone, 3-phenylfuran, 3-(methylthio)propanal, o-hydroxybenzaldehyde, methyl propionate, vinyl butyrate, 2-acetyl-1,4,5,6-tetrahydropyridine, S-methyl thioacetate, 3-methyl-1-butanol, 3-(ethylthio)-propanal, 1-butanol, and methyl methacrylate.
Dependencies are inferred from the claim text.